Yuki Gosei Kogyo Co Ltd (4531) Stock Price & News

4531:TYO

Yuki Gosei Kogyo Co Ltd

¥365.00

-0.54%

(-2.00) 1D

Oct 7, 1:04:16 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4531...

Open

¥368

High

¥369

Low

¥364

Mkt. cap

8.02B

Avg. vol.

31.87K

Volume

5.40K

Dividend

2.74%

Quarterly dividend

¥2

Ex-dividend date

Mar 30, 2026

P/E ratio

18.91

52-wk high

¥640

52-wk low

¥274

EPS

¥19

Shares outstanding

21.83M

No. of employees

296

Open

¥368

High

¥369

Low

¥364

Mkt. cap

8.02B

Avg. vol.

31.87K

Volume

5.40K

Dividend

2.74%

Quarterly dividend

¥2

Ex-dividend date

Mar 30, 2026

P/E ratio

18.91

52-wk high

¥640

52-wk low

¥274

EPS

¥19

Shares outstanding

21.83M

No. of employees

296

Related stocks

4521

Kaken Pharmaceutical Co Ltd

¥3,755.00

-0.40%

4552

JCR Pharmaceuticals Co Ltd

¥487.00

-0.61%

4538

Fuso Pharmaceutical Industries Ltd

¥2,141.00

-0.60%

4547

Kissei Pharmaceutical Co Ltd

¥3,695.00

-0.27%

News stories

From web sources and news partners

CryptoRank

7 minutes ago

Strip Out AI and the S&P 500 Looks Very Different, Goldman Index Shows

RFI

7 hours ago

US stocks hit fresh records as oil stabilizes on rising supplies

BigGo Finance

2 hours ago

S&P 500 Sets Another Record, but Bitcoin's Fate Hinges on Yields and Dollar

TradingView

5 hours ago

S&P 500 And Nasdaq 100 Soar To Record Highs Amid Rising Bets Of Strong Quarterly Earnings — CEG, LCID, SPCX, MRVL In Focus

About Yuki Gosei Kogyo Co Ltd

CEO-

Employees296

FoundedNov 4, 1947

Headquarters-

SectorChemical industry

Websiteyuki-gosei.co.jp

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	3.83B	3.20B	4.43B	4.28B
Cost of goods sold	3.18B	2.52B	3.87B	3.60B
Cost of revenue	3.18B	2.52B	3.87B	3.60B
Research and development expenses	137.00M	143.00M	157.00M	212.00M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	378.00M	428.00M	309.00M	436.00M
Operating expense	515.00M	571.00M	538.00M	648.00M
Total operating expenses	3.70B	3.09B	4.41B	4.24B
Operating income	126.00M	103.00M	19.00M	41.00M
Other non operating income	14.00M	-10.00M	3.00M	-
EBT including unusual items	91.00M	88.00M	75.00M	266.00M
EBT excluding unusual items	99.00M	91.00M	-15.00M	45.00M
Income tax expense	22.00M	15.00M	-	66.00M
Effective tax rate	24.18%	17.05%	-	24.81%
Other operating expenses	-	-	-	-
Net income	69.00M	73.00M	75.00M	200.00M
Net profit margin	1.80%	2.28%	1.69%	4.67%
Earnings per share	-	-	-	-
Interest and investment income	-	30.00M	-	34.00M
Interest expense	-41.00M	-32.00M	-37.00M	-30.00M
Net interest expenses	-41.00M	-2.00M	-37.00M	4.00M
Depreciation and amortization charges	-	-	72.00M	-
EBITDA	471.50M	361.50M	328.50M	350.50M
Gain or loss from assets sale	-	-	-	-

Ask anything